These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2592856

  • 1. Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.
    Massouh M, Jatoi A, Gordon EM, Ratnoff OD.
    J Lab Clin Med; 1989 Dec; 114(6):697-9. PubMed ID: 2592856
    [Abstract] [Full Text] [Related]

  • 2. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P, Bardin JM, Blumenfeld N.
    Thromb Haemost; 1990 Nov 30; 64(3):365-8. PubMed ID: 2096488
    [Abstract] [Full Text] [Related]

  • 3. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 30; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 4. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep 30; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 5. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ, Segal H, Burren T, Gallimore M, Walshe KJ, Robinson G, Machin SJ.
    Blood Coagul Fibrinolysis; 1990 Dec 30; 1(6):647-51. PubMed ID: 2133244
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar 30; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 8. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
    Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B.
    J Clin Invest; 1992 Jan 22; 89(1):321-6. PubMed ID: 1729278
    [Abstract] [Full Text] [Related]

  • 9. [Effect of a combined oral contraceptive on lactation and growth of the infant].
    Peralta O, Díaz S, Juez G, Herreros C, Casado ME, Salvatierra AM, Miranda P, Croxatto H.
    Rev Chil Obstet Ginecol; 1983 Jan 22; 48(5):372-80. PubMed ID: 6681210
    [Abstract] [Full Text] [Related]

  • 10. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H, Lindahl B, Ranstam J, Borg A, Fernö M, Norgren A.
    Anticancer Res; 1987 Jan 22; 7(4B):853-6. PubMed ID: 3674773
    [Abstract] [Full Text] [Related]

  • 11. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA, Bonnar J.
    Thromb Haemost; 1994 Dec 22; 72(6):926-30. PubMed ID: 7740465
    [Abstract] [Full Text] [Related]

  • 12. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS.
    Thromb Haemost; 2002 Jan 22; 87(1):92-7. PubMed ID: 11848463
    [Abstract] [Full Text] [Related]

  • 13. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov 22; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 14. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 22; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Weighing the evidence on the pill and breast cancer.
    Johnson JH.
    Fam Plann Perspect; 1989 Apr 22; 21(2):89-92. PubMed ID: 2653859
    [Abstract] [Full Text] [Related]

  • 17. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep 22; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 18. The effect of oral contraceptives on protein metabolism.
    Amatayakul K, Laokuldilok T, Koottathep S, Dejsarai W, Prapamontol T, Srirak N, Tansuhaj A, Uttaravichai C.
    J Med Assoc Thai; 1994 Oct 22; 77(10):509-16. PubMed ID: 7745371
    [Abstract] [Full Text] [Related]

  • 19. [Oral contraceptives and blood platelets].
    Davenas E, Ciavatti M, Poitevin B, Aubin M.
    Homeopath Fr; 1985 Oct 22; 73(5):299-305. PubMed ID: 12281246
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.